Jared Whitlock


Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Researchers Hunting For Existing Drugs to Repurpose in Fight Against COVID-19

Already Proven Drugs Could Be a Quicker Way to Treat Virus

Tease photo

FDA Opens Door for Virus Diagnostics

MEDICINE: Mesa Biotech Readies 30-Minute Test

Tease photo

Forge Eligible for up to $190M in Antibiotic Deal with Roche

San Diego-based Forge Therapeutics struck an agreement with Roche centering on Forge’s antibiotic for treatment-resistant infections.

Companies Scale Up Production of COVID-19 Tests

Medicine: FDA Relaxes Rules to Aid Efforts

Tease photo

Companies Push Production Of Coronavirus Tests

Medicine: FDA Relaxes Rules to Aid Efforts

Tease photo

DermTech Raises $65M in Private Placement for Skin Cancer Test

Funds To Accelerate Commercialization of Flagship Test

Maravai LifeSciences Acquires MockV Solutions

San Diego’s Maravai LifeSciences has purchased MockV Solutions for undisclosed terms, it was announced March 17.

n-Lorem Foundation Lands $500,000 for Rare Disease Work

The n-Lorem Foundation — a Carlsbad nonprofit that formed to supply individualized therapies free of charge to patients with ultra-rare genetic diseases — has received a $500,000 pledge.

San Diego Biotechs Forge Ahead on Potential COVID-19 Vaccines

MEDICINE: Arcturus Receives $10M From Singapore Agency

Tease photo

Mesa Biotech Developing Rapid COVID-19 Test

Laboratory-Quality Results May Be Possible in 30 Minutes

Alphatec to Buy EOS Imaging in $121.9M Deal

If the Sale Goes Smoothly, It Should Close in Fourth Quarter

Mesa Biotech Developing Rapid COVID-19 Test

Mesa Biotech is developing a COVID-19 test that aims to tell if someone has the virus in 30 minutes, amid clamoring to get answers faster as the deadly strain spreads.

Tease photo

Co. to Use Body’s Innate Immune System Against Cancer

Primmune Therapeutics Raises $7 Million in Seed Round

PvP Deal Could Be Worth More Than $330M

ACQUISITION: Takeda Gets Drug to Possibly Treat Celiac Disease

Arcturus Lands up to $10M for Potential Coronavirus Vaccine

Arcturus said its vaccine could be effective at lower doses than other RNA-based medicines, reducing the time and cost to vaccinate large populations.

Forte Biosciences Gets Nasdaq Listing After Tocagen Merger

FDA Decision on Opioid Alternative Delayed; Genomics Co. Has Series A

Alphatec to Buy EOS Imaging in $121.9M Deal

Carlsbad-based Alphatec has agreed to acquire EOS Imaging in a $121.9 million deal.

Device Cos. Report Solid Earnings

MEDICINE: Dexcom ResMed Have Strong Q4 Revenue

Tease photo

Company Gets $1 Million From Gates Foundation for Tuberculosis Testing

Company Is Developing Portable System to Detect Tuberculosis

DTx Takes on Delivery of RNA Meds

Pharma: Co. Came Through S.D. Ecosystem, Raises $10.6 Million

Ligand Pharmaceuticals Purchase Of Icagen Brings Partnerships, Platform

Icagen Inc. Is ‘Cash-Flow Positive and Profitable Business’

Vividion Recruits Former Pfizer Exec For C-Suite

Company Is Targeting ‘Undruggable’ Proteins

Biological Dynamics Gets $1M from Gates Foundation for Tuberculosis Test

San Diego’s Biological Dynamics is set to receive a $1 million grant from the Bill & Melinda Gates Foundation to push forward its tuberculosis test.

Haynes and Kearns Join Board of Sanford Burnham Prebys Medical Discovery Institute

Sanford Burnham Prebys Medical Discovery Institute has made two additions to its board who are well known in San Diego’s education and health care circles: Karen Haynes and Donald Kearns.

Robotic Lab Is an Experiment Itself

BIOTECH: Aims Are Research, Relationships

Tease photo

La Jolla Laser Vision & Eye Center Acquired

Acuity Eye Group has purchased La Jolla Laser Vision & Eye Center for an undisclosed amount.

Vividion Therapeutics Lures Former Pfizer Executive

Vividion Therapeutics – a San Diego upstart that last year raised an $82 million financing round – has announced the hiring of a former Pfizer executive.

Illumina Adds Scott Gottlieb To Its Board

Former FDA Commissioner Left Post in April

Neurocrine Beats Analysts Forecast For Fourth Quarter

Marketing to Patients, Caregivers Proves Successful

ResMed’s Q2 Net Income Increased 29% to $160.6 Million

Masks And Accessories Segment Grew in High Teens

Tease photo

Carlsbad Nonprofit Awarded $450K Chan-Zuckerberg Grant

The Grant Will Support Research, Infrastructure Needs

Biotechs in San Diego Join Race to Combat Coronavirus

MEDICINE: Investor Interest Swirls around Companies

A crop of life sciences companies are rushing to combat the coronavirus outbreak, triggering big movements in their stocks and millions in grant funding.

Tease photo

Illumina Adds Former FDA Commissioner to Board

Illumina recently made a major addition to its board: Scott Gottlieb, the former commissioner of the U.S. Food and Drug Administration.

Histogen Gets Nasdaq Listing Via Merger With Conatus

All Stock Transaction Gives Histogen 74% of Shares

Gates Foundation Awards $50M to Scripps Research

The Bill & Melinda Gates Foundation has awarded $50 million to a division of Scripps Research to push forward potential therapies for tuberculosis and malaria.

Carlsbad Nonprofit Awarded $450K Chan-Zuckerberg Grant

The Association for Creatine Deficiencies was awarded a $450,000 grant to combat a trio of disorders that can cause intellectual delays.

MeBe to Open Autism and Special Needs Center in Kearny Mesa

San Diego company MeBe on Feb. 15 is slated to open a center catering to young adults and children with autism and special needs.

Histogen to Go Public Via Merger With Conatus

Conatus Pharmaceuticals has agreed to merge with another San Diego biotech, Histogen, it was announced Jan. 28.

Sorrento Therapeutics Passes on $1.17B Offer

PHARMA: Three Bids Made for Co. Working On Opioid Alternative

Illumina Announces Its Q4 Results

Illumina reported revenue of $953 million in fourth quarter revenue.

Biotech Awarded up to $9M to Develop Coronavirus Vaccine

Inovio Pharmaceuticals was recently awarded up to a $9 million grant to develop a vaccine against a strain of coronavirus that’s spreading in China and spurred screening at U.S. airports.

Illumina Reports 10% Revenue Increase in Q4

Illumina reported revenue of $953 million in fourth quarter revenue, a 10% year-over-year increase that also beat analyst expectations.

Tyra Biosciences Raises $50 Million In Cancer Fight

Co. Targets Cancers That Have Become Drug Resistant

Device Companies See Advantage In Partnering With Big Tech

From Hardware to Data, Verily Helping Local Companies Better Cater to Consumer Needs

Tease photo

ResMed Settles Kickback Allegations, Agrees to Pay $37.5M

ResMed will pay $37.5 million to settle allegations that the company paid kickbacks to suppliers, sleep labs and other health care providers, the Department of Justice recently announced.

Actor Gets Role at Scripps Bridging Communication Gap

Inovio Awarded $9M for Coronavirus Research

Tease photo

Tyra Biosciences Raises $50M to Take On Drug Resistant Cancers

Tyra Biosciences, a Carlsbad company that wants to combat cancers that become drug-resistant, has raised a $50 million round.

Cos. Find Deals, Dollars at J.P. Morgan

BIOTECH: HL Buys, Sells; New Partnership Unveiled for Illumina

Debut Looks to Move Drug Manufacturing Forward

San Diego-Based Co. Closes $2.6 Million Seed Round